MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
Recruiting
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT05193981
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Supraglottic Airway Needed To Achieve Ventilation
Completed
- Conditions
- Airway Complication of AnesthesiaDifficult or Failed Intubation
- Interventions
- Other: Airway and Ventilation
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 54
- Registration Number
- NCT05190757
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
Phase 2
Recruiting
- Conditions
- Acquired Nephrogenic Diabetes InsipidusCongenital Nephrogenic Diabetes InsipidusAutosomal Dominant Polycystic Kidney DiseaseNephrogenic Diabetes Insipidus
- Interventions
- Drug: PB
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT05190744
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty
Phase 4
Completed
- Conditions
- Total Knee Arthroplasty
- Interventions
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 209
- Registration Number
- NCT05188053
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Acute Kidney Injury in Care Transitions
Not Applicable
Completed
- Conditions
- Acute Kidney Injury
- Interventions
- Behavioral: AKI in Care Transitions (ACT) program
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT05184894
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
Phase 2
Recruiting
- Conditions
- Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC V8Stage IV Hepatocellular Carcinoma AJCC V8Unresectable Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT05176223
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Complications Associated With Primary Placement of Gastrostomy for Feeding
Not Applicable
Completed
- Conditions
- Gastrostomy Tube
- Interventions
- Procedure: Radiologically-inserted gastrostomyProcedure: Percutaneous endoscopic gastrostomy
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 43
- Registration Number
- NCT05173935
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
IBD and Women's Health Wellness Program
Not Applicable
Completed
- Conditions
- Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
- Interventions
- Behavioral: Wellness ProgramBehavioral: Wellness Coaching
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT05172557
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Practical Anemia Bundle for SusTained Blood Recovery
Phase 2
Active, not recruiting
- Conditions
- Critical IllnessAnemia
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT05167734
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
Phase 2
Recruiting
- Conditions
- Multiple System Atrophy
- Interventions
- Biological: Autologous Mesenchymal Stem CellsOther: Placebo
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 76
- Registration Number
- NCT05167721
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath